BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4449793)

  • 1. [Anabolic steroide hormones. The problems of testing and the structure-activity relationshipA1].
    Pivnitskiĭ KK
    Probl Endokrinol (Mosk); 1974; 20(4):111-22. PubMed ID: 4449793
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anabolic activity of 9, 10-dehydro-19-nortestosterone derivatives].
    Ivanenko TI; Shishkina AA; Rzheznikov VM; Pivnitskiĭ KK
    Probl Endokrinol (Mosk); 1974; 20(4):83-8. PubMed ID: 4453568
    [No Abstract]   [Full Text] [Related]  

  • 3. A Hansch analysis of the anabolic activities of some nandrolone esters.
    Chaudry AQ; James KC
    J Med Chem; 1974 Feb; 17(2):157-61. PubMed ID: 4809250
    [No Abstract]   [Full Text] [Related]  

  • 4. Anabolic agents. 2,3-Epithioandrostane derivatives.
    Klimstra PD; Nutting EF; Counsell RE
    J Med Chem; 1966 Sep; 9(5):693-7. PubMed ID: 5969041
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
    Lovejoy JC; Bray GA; Greeson CS; Klemperer M; Morris J; Partington C; Tulley R
    Int J Obes Relat Metab Disord; 1995 Sep; 19(9):614-24. PubMed ID: 8574271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of androgens and anabolic steroids on the plasma disappearance curve and the distribution of (1,2- 3 H) corticosterone in the rat.
    Linèt O; Lomen P
    Acta Endocrinol (Copenh); 1971 Oct; 68(2):303-10. PubMed ID: 5171468
    [No Abstract]   [Full Text] [Related]  

  • 7. Myotrophic effects of anabolic steroids.
    Salmons S
    Vet Res Commun; 1983 Dec; 7(1-4):19-26. PubMed ID: 6665983
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myotrophic and androgenic activity of certain steroids depending on the duration of action].
    Ivanenko TI; Shishkina AA; Pivnitskiĭ KK; Fedotov VP
    Probl Endokrinol (Mosk); 1974; 20(6):60-4. PubMed ID: 4453569
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of biological model of isolated overloading of skeletal muscle for determination of anabolic effect of steranobols.
    Ivanenko TI; Fedotov VP; Almaeva SN; Belen'kii EE
    Neurosci Behav Physiol; 1980; 10(3):223-7. PubMed ID: 7413077
    [No Abstract]   [Full Text] [Related]  

  • 10. Aggression in male rats receiving anabolic androgenic steroids: effects of social and environmental provocation.
    Breuer ME; McGinnis MY; Lumia AR; Possidente BP
    Horm Behav; 2001 Nov; 40(3):409-18. PubMed ID: 11673914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anabolic steroids and growth].
    Bierich JR
    Munch Med Wochenschr; 1971 Jun; 113(25):942-8. PubMed ID: 4996666
    [No Abstract]   [Full Text] [Related]  

  • 12. Anabolic androgens restore mating after sexual satiety in male rats.
    Phillips-Farfán BV; Romano-Torres M; Fernández-Guasti A
    Pharmacol Biochem Behav; 2008 May; 89(3):241-6. PubMed ID: 18234307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status of anabolic steroid therapy].
    Cuenca E
    Munch Med Wochenschr; 1971 Jun; 113(25):937-42. PubMed ID: 4932439
    [No Abstract]   [Full Text] [Related]  

  • 14. Estradienes and 2-oxaestradienes. Potent oral anabolic-androgenic agents.
    Nutting EF; Calhoun DW
    Endocrinology; 1969 Feb; 84(2):441-2. PubMed ID: 5764313
    [No Abstract]   [Full Text] [Related]  

  • 15. [Parallelism between nephrocalcitopotropic and estrogenic activity of some anabolic steroids, androgens, progestational hormones and estrogens].
    Pohle K; Bekemeier H
    Endokrinologie; 1968 Feb; 52(5):362-5. PubMed ID: 4302947
    [No Abstract]   [Full Text] [Related]  

  • 16. [Enol-derivatives of 1-methyl-delta-1-5-alpha-androsten-17-beta-ol-3-on. V. On 1-methyl-steroids].
    Müller H; Neumann F; Wiechert R
    Arzneimittelforschung; 1966 Nov; 16(11):1515-8. PubMed ID: 6014969
    [No Abstract]   [Full Text] [Related]  

  • 17. Anabolic and androgenic activity of 19-norandrostenedione after oral and subcutaneous administration--analysis of side effects and metabolism.
    Parr MK; Laudenbach-Leschowsky U; Höfer N; Schänzer W; Diel P
    Toxicol Lett; 2009 Jul; 188(2):137-41. PubMed ID: 19446246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic administration of the anabolic androgenic steroid nandrolone alters neurosteroid action at the sigma-1 receptor but not at the sigma-2 or NMDA receptors.
    Elfverson M; Johansson T; Zhou Q; Le Grevès P; Nyberg F
    Neuropharmacology; 2011 Dec; 61(7):1172-81. PubMed ID: 21251916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in neuromuscular performance and muscle fiber characteristics of elite power athletes self-administering androgenic and anabolic steroids.
    Alén M; Häkkinen K; Komi PV
    Acta Physiol Scand; 1984 Dec; 122(4):535-44. PubMed ID: 6524396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the endogenous hormonal background due to anabolic steroids].
    Chermnykh NS; Andreev IuA; Syrov VN
    Eksp Klin Farmakol; 1992; 55(1):40-2. PubMed ID: 1305432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.